New research suggests changes in the gut microbiome may significantly influence artery health, inflammation, and the risk of peripheral artery disease (PAD). A recent review indicates that disruptions in gut bacteria could be a key factor in the development of atherosclerosis and PAD, alongside traditional risks like diet, diabetes, hypertension, smoking, and obesity.
This imbalance, known as gut dysbiosis, may drive vascular damage. Studies show higher levels of pro-inflammatory bacteria and reduced levels of beneficial bacteria that produce protective short-chain fatty acids (SCFAs) in individuals with vascular disease.
Two critical gut-derived metabolites are involved: trimethylamine N-oxide (TMAO), linked to increased vascular risk, and SCFAs, which appear to offer protection through anti-inflammatory effects and improved metabolic health.
The gut microbiome's connection to PAD is increasingly evident, with specific bacterial groups associated with either increased or decreased disease risk. Proposed mechanisms include altered SCFA production, heightened inflammation, and changes in nitric oxide activity.
While interventions like probiotics, prebiotics, and dietary changes such as the Mediterranean diet are being explored to improve gut health, researchers emphasize that these approaches are still investigational. More extensive clinical trials are needed to establish them as reliable tools for vascular prevention and treatment.